Key Takeaways
- Harrow partners with Asembia to launch nationwide digital services for eyecare products.
- The partnership simplifies the prescription process and improves accessibility and affordability.
- ASPN Pharmacies collaborates with prescribers, patients, and payers to ensure rapid delivery and excellent patient experience.
- Advanced support centers enable seamless prescription submission and refill automation.
In a significant step forward for the eyecare industry, Harrow has teamed up with Asembia to roll out a comprehensive digital solution designed to streamline access to its branded ophthalmic products across the United States.
This partnership aims to simplify the prescription process for eyecare professionals and enhance the affordability and accessibility of critical medications for patients. By leveraging advanced technology and a robust support network, Harrow and Asembia are poised to transform the patient experience, ensuring that vital eyecare treatments reach those who need them most efficiently and cost-effectively.
Enhanced Access and Affordability
Harrow, a leader in the eyecare pharmaceutical sector, has unveiled a new digital patient access solution in collaboration with Asembia, a top provider of specialty pharmacy services. This multi-year exclusive partnership focuses on expanding the reach of Harrow’s branded eyecare products like FLAREX, ILEVRO, and others.
By simplifying the prescription process, the collaboration aims to improve both access and affordability for patients. The initiative involves ASPN Pharmacies, Asembia’s non-dispensing pharmacy, which utilizes cutting-edge technology to facilitate collaboration between prescribers, patients, and payers.
Seamless Prescription Process
Mark L. Baum, CEO of Harrow, emphasizes that the partnership with Asembia and the utilization of ASPN will break down barriers to accessing and affording branded eyecare products. The collaboration streamlines the patient journey from prescription intake to benefits verification, including prior authorization, co-pay support, and patient assistance eligibility.
ASPN’s advanced support centers allow providers to submit prescriptions through EHR/EMR systems seamlessly, while automating the refill process, enabling patients to begin therapies quickly at minimal out-of-pocket costs.
Lawrence Irene, CEO of Asembia, highlights the importance of offering Harrow’s market-leading ophthalmic products. By partnering with Harrow, Asembia enhances the availability of essential treatments, making them more accessible and affordable. The advanced patient and provider portal offers complete transparency and support, empowering stakeholders throughout the prescription process.
Strategic Partnerships
In the current landscape of healthcare, where access and affordability remain significant challenges, Harrow’s collaboration with Asembia offers a promising solution for eyecare professionals and patients. By focusing on simplifying the prescription process and enhancing support networks, this partnership not only facilitates the timely delivery of medications but also reduces financial burdens on patients.
As healthcare continues to evolve, such innovative collaborations become crucial in ensuring that patients receive the care they need without unnecessary delays or costs. This initiative not only highlights the importance of technology in modern healthcare but also sets a precedent for future collaborations aimed at improving patient outcomes through strategic partnerships.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
